153 related articles for article (PubMed ID: 14762854)
1. Switching monitoring of emulsified cyclosporine from trough level to 2-hour level in stable liver transplant patients.
Langers P; Cremers SC; den Hartigh J; Veenendaal RA; ten Hove WR; Ringers J; Lamers CB; van Hoek B
Liver Transpl; 2004 Feb; 10(2):183-9. PubMed ID: 14762854
[TBL] [Abstract][Full Text] [Related]
2. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
3. Conversion to microemulsion cyclosporine in stable renal transplant patients: results after one year.
Neumayer HH; Budde K; Färber L; Haller P; Kohnen R; Maibücher A; Schuster A; Vollmar J; Waiser J; Luft FC
Clin Nephrol; 1996 May; 45(5):326-31. PubMed ID: 8738665
[TBL] [Abstract][Full Text] [Related]
4. Achieving adequate cyclosporine exposure in liver transplant recipients: a novel strategy for monitoring and dosing using intravenous therapy.
Lück R; Böger J; Kuse E; Klempnauer J; Nashan B
Liver Transpl; 2004 May; 10(5):686-91. PubMed ID: 15108262
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH
Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
[TBL] [Abstract][Full Text] [Related]
6. Monitoring C2 level predicts exposure in maintenance lung transplant patients receiving the microemulsion formulation of cyclosporine (Neoral).
Jaksch P; Kocher A; Neuhauser P; Sarahrudi K; Seweryn J; Wisser W; Klepetko W
J Heart Lung Transplant; 2005 Aug; 24(8):1076-80. PubMed ID: 16102443
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporine pharmacokinetics and blood pressure responses after conversion to once-daily dosing in maintenance liver transplant patients.
Kovarik JM; Villamil F; Otero A; Levy G; Lynch S; Cillo U; Fischer L; Nashan B; Pollard S; De Carlis L
Clin Transplant; 2008; 22(1):68-75. PubMed ID: 18217908
[TBL] [Abstract][Full Text] [Related]
8. Determination of area under the whole blood concentration versus time curve after first intravenous cyclosporine dose in children undergoing hematopoietic stem cell transplant: limited sampling strategies.
Sibbald C; Seto W; Taylor T; Saunders EF; Doyle J; Dupuis LL
Ther Drug Monit; 2008 Aug; 30(4):434-8. PubMed ID: 18641547
[TBL] [Abstract][Full Text] [Related]
9. Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose.
Sukhavasharin N; Praditpornsilpa K; Avihingsanon Y; Kuoatawintu P; O-Charoen R; Kansanabuch T; Tungsanga K; Eiam-Ong S
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S15-20. PubMed ID: 17044449
[TBL] [Abstract][Full Text] [Related]
10. Comparison of pharmacokinetics of Neoral and Sandimmune in stable pediatric liver transplant recipients.
van Mourik ID; Thomson M; Kelly DA
Liver Transpl Surg; 1999 Mar; 5(2):107-11. PubMed ID: 10071349
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine dose reduction in stable renal transplant patients with high C2 level: simplified method of single C2 measurement and individualization of C0 target.
Higgins RM; Kanji H; Hernon M; Harrison P; Lam FT; Kashi SH
Transpl Int; 2005 Jul; 18(7):806-10. PubMed ID: 15948859
[TBL] [Abstract][Full Text] [Related]
12. Limitations of cyclosporine C2 monitoring in pediatric heart transplant recipients.
Hmiel SP; Canter C; Shepherd R; Lassa-Claxton S; Nadler M
Pediatr Transplant; 2007 Aug; 11(5):524-9. PubMed ID: 17631021
[TBL] [Abstract][Full Text] [Related]
13. Suitable whole blood levels 2 hours after neoral in liver transplant patients: experiences at a single center.
Kim KH; Lee SG; Lee YJ; Park KM; Hwang S; Ahn CS; Moon DB; Ha TY; Song KW; Kim DS; Jung DH; Kim BS; Moon KM; Lee HJ; Park JI; Ryu JH
Transplant Proc; 2006 Nov; 38(9):2971-3. PubMed ID: 17112877
[TBL] [Abstract][Full Text] [Related]
14. Impact of late conversion from C0 to C2 monitoring of microemulsified cyclosporine in pediatric living donor liver transplant recipients.
Takatsuki M; Chen CL; Chen YS; Wang CC; Lin CC; Yang CH; Yong CC; Liu YW
Clin Transplant; 2004 Dec; 18(6):694-9. PubMed ID: 15516246
[TBL] [Abstract][Full Text] [Related]
15. Time-dependent changes in cyclosporine exposure: implications for achieving target concentrations.
Felipe CR; Silva HT; Machado PG; Garcia R; Moreira SR; Pestana JO
Transpl Int; 2003 Jul; 16(7):494-503. PubMed ID: 12677364
[TBL] [Abstract][Full Text] [Related]
16. C2 monitoring of cyclosporine in de novo liver transplant recipients: the clinician's perspective.
Villamil F; Pollard S
Liver Transpl; 2004 May; 10(5):577-83. PubMed ID: 15108248
[TBL] [Abstract][Full Text] [Related]
17. Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation.
Rodríguez E; Delucchi MA; Cano F; Valdebenito S; Castillo MC; Villegas R
Transplant Proc; 2005 Oct; 37(8):3354-7. PubMed ID: 16298594
[TBL] [Abstract][Full Text] [Related]
18. The area under the concentration-time curve versus trough and peak blood level monitoring in renal transplant recipients on cyclosporine.
Halim MA; Nampoory MR; Johny KV; Donia F; Hamid MH; Said T; Nair MP; Mansour M; Al-Muzairai I; Samhan M; Al-Mousawi M
Transplant Proc; 2005 Sep; 37(7):3019-21. PubMed ID: 16213291
[TBL] [Abstract][Full Text] [Related]
19. Is 3-hour cyclosporine blood level superior to trough level in early post-renal transplantation period?
Mahalati K; Lawen J; Kiberd B; Belitsky P
J Urol; 2000 Jan; 163(1):37-41. PubMed ID: 10604309
[TBL] [Abstract][Full Text] [Related]
20. Individualized population pharmacokinetic model with limited sampling for cyclosporine monitoring after liver transplantation in clinical practice.
Langers P; Cremers SC; den Hartigh J; Rijnbeek EM; Ringers J; Lamers CB; Hommes DW; van Hoek B
Aliment Pharmacol Ther; 2007 Nov; 26(10):1447-54. PubMed ID: 17848182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]